- Home
- AVIR vs DRDB Comparison
AVIR vs DRDB Comparison
Compare AVIR & DRDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- DRDB
- Stock Information
- Founded
- AVIR 2012
- DRDB 2024
- Country
- AVIR United States
- DRDB United States
- Employees
- AVIR N/A
- DRDB N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- DRDB
- Sector
- AVIR Health Care
- DRDB
- Exchange
- AVIR Nasdaq
- DRDB Nasdaq
- Market Cap
- AVIR 273.0M
- DRDB 316.5M
- IPO Year
- AVIR 2020
- DRDB 2024
- Fundamental
- Price
- AVIR $3.90
- DRDB $10.28
- Analyst Decision
- AVIR Hold
- DRDB
- Analyst Count
- AVIR 1
- DRDB 0
- Target Price
- AVIR $6.00
- DRDB N/A
- AVG Volume (30 Days)
- AVIR 426.9K
- DRDB 118.1K
- Earning Date
- AVIR 08-06-2025
- DRDB 01-01-0001
- Dividend Yield
- AVIR N/A
- DRDB N/A
- EPS Growth
- AVIR N/A
- DRDB N/A
- EPS
- AVIR N/A
- DRDB N/A
- Revenue
- AVIR N/A
- DRDB N/A
- Revenue This Year
- AVIR N/A
- DRDB N/A
- Revenue Next Year
- AVIR N/A
- DRDB N/A
- P/E Ratio
- AVIR N/A
- DRDB $587.82
- Revenue Growth
- AVIR N/A
- DRDB N/A
- 52 Week Low
- AVIR $2.46
- DRDB $9.87
- 52 Week High
- AVIR $4.15
- DRDB $10.43
- Technical
- Relative Strength Index (RSI)
- AVIR 67.66
- DRDB N/A
- Support Level
- AVIR $3.36
- DRDB N/A
- Resistance Level
- AVIR $3.53
- DRDB N/A
- Average True Range (ATR)
- AVIR 0.15
- DRDB 0.00
- MACD
- AVIR -0.00
- DRDB 0.00
- Stochastic Oscillator
- AVIR 97.24
- DRDB 0.00
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About DRDB Roman DBDR Acquisition Corp. II Ordinary shares
Roman DBDR Acquisition Corp II is a blank check company.